https://www.selleckchem.com/products/wh-4-023.html
7, 2014). Novel therapies and new targets required for developing more effective drugs for the treatment of AD patients are urgently needed.Lipids constitute almost 60% of the brain's dry weight, and they are thought to be involved in inflammation, neurotransmission and synaptic plasticity. The brain mostly contains sphingolipids, glycerophospholipids and cholesterol which are abundant in myelin and neuronal membranes. The recent rise of the promising area of lipidomic data can be used as a diagnosing tool at the early stages of Alzhei
Like
Comment
Share
